Gerald Slagel, MD
Dermatology · Fayetteville, GANPI 1003966094
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 28.9% of the total. That places this record below the midpoint for dermatology clinicians in GA, where the typical reported total is $3,907.
Across 148 payments — averaging $20.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$879
- Sanofi$628
- Johnson & Johnson$262
- Amgen$209
- Pfizer$163
- Sun Pharmaceutical Industries Inc.$155
- plus $746 from 16 others
Across 110 payments — averaging $11,296 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$883K
- GSK$254K
- Amgen$89K
- Sun Pharmaceutical Industries Inc.$17K
What the payments were for
- Food & beverage$2,95397%
- Education$903%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $879 |
| Sanofi | 25 | $628 |
| Johnson & Johnson | 10 | $262 |
| Amgen | 10 | $209 |
| Pfizer | 9 | $163 |
| Sun Pharmaceutical Industries Inc. | 9 | $155 |
| Regeneron Healthcare Solutions, Inc. | 6 | $137 |
| Arcutis Biotherapeutics, Inc. | 6 | $123 |
| LEO Pharma Inc. | 5 | $102 |
| Lilly USA, LLC | 4 | $83 |
| Incyte Corporation | 2 | $47 |
| Galderma Laboratories, L.p. | 2 | $32 |
| Almirall LLC | 2 | $30 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $29 |
| Bristol Myers Squibb | 1 | $26 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| Medtronic | 1 | $22 |
| Novartis | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
| Dermira, Inc. | 1 | $17 |
| Merck | 1 | $16 |
| UCB, Inc. | 1 | $15 |
How this compares
$3,043 in reported general payments places this provider in the 40th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 671 | $5,291 |
| Triamcinolone Acetonide | 64 | $826 |
| Metronidazole | 13 | $775 |
| Clindamycin Phosphate | 24 | $524 |
| Mometasone Furoate | 24 | $405 |
| Clobetasol Propionate | 14 | $343 |
| Ketoconazole | 42 | $306 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 83 | $292 |
| Hydrocortisone | 50 | $279 |
| Econazole Nitrate | 13 | $247 |
| Mupirocin | 31 | $226 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 33 | $130 |
| Cephalexin | 21 | $124 |
| Terbinafine Hcl | 11 | $83 |
| ValacyclovirValacyclovir Hcl | 13 | $71 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fayetteville
- Firas HougeirDouglasville$3.1M
- David CohenMacon$2.9M
- Zakiya RiceAtlanta$1.1M
- Joseph PayneAtlanta$711K
- Jonathan WeissSnellville$692K
- Jamie WeismanAtlanta$620K
- Mack RachalAtlanta$260K
- Tiffany Clay-RamseyMarietta$207K
- Jessica MercerSnellville$183K
- Sumayah TaliaferroAtlanta$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.